Cargando…
The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892756/ https://www.ncbi.nlm.nih.gov/pubmed/36741052 http://dx.doi.org/10.3389/fnins.2022.980658 |
_version_ | 1784881383744733184 |
---|---|
author | Wang, Xiaoyan Chen, Xiaohui Tang, Yuting Zhang, Liuping Wang, Yue Hou, Zhenghua Jang, Wenhao Yuan, Yonggui |
author_facet | Wang, Xiaoyan Chen, Xiaohui Tang, Yuting Zhang, Liuping Wang, Yue Hou, Zhenghua Jang, Wenhao Yuan, Yonggui |
author_sort | Wang, Xiaoyan |
collection | PubMed |
description | BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage renal disease. MATERIALS AND METHODS: This prospective study evaluated patients with end-stage renal disease undergoing blood purification from January to March 2021. Matched healthy controls were also included. Participants performed neurocognitive measurements, including a mini-mental state examination, logical memory test-20-minutes delayed, verbal fluency test, digit span test, clock drawing test, and stroop color and word test C. In addition, we tested plasma amyloid-β protein levels, serum Fe and hemoglobin levels in blood samples. Cerebral blood flow was measured using pulsed pseudocontinuous arterial spin labeling. We analyzed and compared the correlation between cognitive function, biomarkers, and cerebral blood flow between patients and healthy subjects, as well as between patients with different treatments. RESULTS: A total of 44 patients with end-stage renal disease (mean age, 57.39 years ± 8.63) and 46 healthy controls (mean age, 56.15 years ± 6.40) were recruited. Patients receive hemodialysis three times a week, and 27 of them have been replaced hemodialysis for hemodiafiltration twice a month. The cognitive function of patients was worse than healthy controls (P < 0.05). The patients showed higher plasma concentrations of amyloid-β40, amyloid-β42, Tau, and pTau181 than healthy controls (P < 0.05). The group receiving both hemodialysis and hemodiafiltration had higher cerebral blood flow signal values in the left caudate nucleus (chuster-level P < 0.05, voxel-level P < 0.001). They also exhibited better verbal fluency function than the hemodialysis-only group (P < 0.05). CONCLUSION: Patients with the end-stage renal disease showed widespread cognitive declines. Cerebral blood flow generally decreased in the cerebral cortex and increased in subcortical regions. The hemodiafiltration may protect verbal function by increasing cerebral blood flow in the left caudate. |
format | Online Article Text |
id | pubmed-9892756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98927562023-02-03 The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease Wang, Xiaoyan Chen, Xiaohui Tang, Yuting Zhang, Liuping Wang, Yue Hou, Zhenghua Jang, Wenhao Yuan, Yonggui Front Neurosci Neuroscience BACKGROUND: Patients with end-stage renal disease are more likely to suffer cognitive impairment. Cognitive impairment may lead to long-term severe adverse consequences. PURPOSE: To explore the impact of different blood purification therapy on cerebral blood flow and cognitive functions in end-stage renal disease. MATERIALS AND METHODS: This prospective study evaluated patients with end-stage renal disease undergoing blood purification from January to March 2021. Matched healthy controls were also included. Participants performed neurocognitive measurements, including a mini-mental state examination, logical memory test-20-minutes delayed, verbal fluency test, digit span test, clock drawing test, and stroop color and word test C. In addition, we tested plasma amyloid-β protein levels, serum Fe and hemoglobin levels in blood samples. Cerebral blood flow was measured using pulsed pseudocontinuous arterial spin labeling. We analyzed and compared the correlation between cognitive function, biomarkers, and cerebral blood flow between patients and healthy subjects, as well as between patients with different treatments. RESULTS: A total of 44 patients with end-stage renal disease (mean age, 57.39 years ± 8.63) and 46 healthy controls (mean age, 56.15 years ± 6.40) were recruited. Patients receive hemodialysis three times a week, and 27 of them have been replaced hemodialysis for hemodiafiltration twice a month. The cognitive function of patients was worse than healthy controls (P < 0.05). The patients showed higher plasma concentrations of amyloid-β40, amyloid-β42, Tau, and pTau181 than healthy controls (P < 0.05). The group receiving both hemodialysis and hemodiafiltration had higher cerebral blood flow signal values in the left caudate nucleus (chuster-level P < 0.05, voxel-level P < 0.001). They also exhibited better verbal fluency function than the hemodialysis-only group (P < 0.05). CONCLUSION: Patients with the end-stage renal disease showed widespread cognitive declines. Cerebral blood flow generally decreased in the cerebral cortex and increased in subcortical regions. The hemodiafiltration may protect verbal function by increasing cerebral blood flow in the left caudate. Frontiers Media S.A. 2023-01-19 /pmc/articles/PMC9892756/ /pubmed/36741052 http://dx.doi.org/10.3389/fnins.2022.980658 Text en Copyright © 2023 Wang, Chen, Tang, Zhang, Wang, Hou, Jang and Yuan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Wang, Xiaoyan Chen, Xiaohui Tang, Yuting Zhang, Liuping Wang, Yue Hou, Zhenghua Jang, Wenhao Yuan, Yonggui The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title | The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title_full | The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title_fullStr | The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title_full_unstemmed | The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title_short | The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
title_sort | impact of hemodiafiltration on cognitive function in patients with end-stage renal disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892756/ https://www.ncbi.nlm.nih.gov/pubmed/36741052 http://dx.doi.org/10.3389/fnins.2022.980658 |
work_keys_str_mv | AT wangxiaoyan theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT chenxiaohui theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT tangyuting theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT zhangliuping theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT wangyue theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT houzhenghua theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT jangwenhao theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT yuanyonggui theimpactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT wangxiaoyan impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT chenxiaohui impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT tangyuting impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT zhangliuping impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT wangyue impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT houzhenghua impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT jangwenhao impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease AT yuanyonggui impactofhemodiafiltrationoncognitivefunctioninpatientswithendstagerenaldisease |